SMSPHARMA.BOSMSPHARMA.BOBSE
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank57
3Y CAGR+2.8%
5Y CAGR+22.5%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+2.8%/yr
vs -15.5%/yr prior
5Y CAGR
+22.5%/yr
Recent deceleration
Acceleration
+18.3pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
2.8x
Strong expansion
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 15.45% |
| 2024 | 24.60% |
| 2023 | 6.26% |
| 2022 | 14.22% |
| 2021 | -1.21% |
| 2020 | 5.61% |
| 2019 | 36.95% |
| 2018 | 27.89% |
| 2017 | 15.59% |
| 2016 | 51.55% |